%PDF-1.4
%
72 0 obj
<>
endobj
59 0 obj
<>
endobj
60 0 obj
<>stream
application/pdf
untitled
2013-12-20T18:10:29+05:30
Arbortext Advanced Print Publisher 9.1.520/W Unicode
2017-05-03T06:29:46-07:00
2017-05-03T06:29:46-07:00
Acrobat Distiller 10.1.5 (Windows)
uuid:747f29cf-54b4-41c8-8754-eecd6f4e6d2d
uuid:bdbd7037-1dd1-11b2-0a00-c9009852adff
endstream
endobj
56 0 obj
<>
endobj
58 0 obj
<>
endobj
73 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 48 0 R/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 50 0 R/Type/Page>>
endobj
8 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 52 0 R/Type/Page>>
endobj
19 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 53 0 R/Type/Page>>
endobj
23 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 54 0 R/Type/Page>>
endobj
29 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 55 0 R/Type/Page>>
endobj
136 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
164 0 obj
[169 0 R 170 0 R 171 0 R 172 0 R 173 0 R 174 0 R 175 0 R 176 0 R 177 0 R 178 0 R 179 0 R 180 0 R 181 0 R]
endobj
165 0 obj
<>stream
q
61.5 0 0 38.75 103.25 714.25 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
15 0 0 15 184 662.99985 Tm
(proof-of-concept trial)Tj
0 1 TD
(double-blind, placebo-controlled, phase II)Tj
T*
(psoriatic arthritis: a 24-week, randomised, )Tj
0 1.00001 TD
(antibody, in patients with moderate-to-severe)Tj
0 1 TD
(human anti-interleukin-17A monoclonal )Tj
T*
(Efficacy and safety of secukinumab, a fully)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 184 618.99991 Tm
(Arthur P Bertolino, Wolfgang Hueber and Paul P Tak)Tj
T*
(Schulze-Koops, Joseph Kogan, Shenglin Ma, Martin M Schumacher,)Tj
0 1.00001 TD
(der Heijde, John D Isaacs, Georg Dahmen, J\374rgen Wollenhaupt, Hendrik \
)Tj
0 1 TD
(Iain B McInnes, Joachim Sieper, J\374rgen Braun, Paul Emery, D\351sir\351\
e van)Tj
ET
BT
/T1_1 1 Tf
12 0 0 12 184 572.99994 Tm
(doi: 10.1136/annrheumdis-2012-202646)Tj
10 0 0 10 184 584.99997 Tm
(2013)Tj
7.28 1 Td
(2014 73: 349-356 originally published online January 29,)Tj
/T1_2 1 Tf
-7.28 0 Td
(Ann Rheum Dis\240)Tj
ET
84 559 m
511 559 l
0 0 m
S
BT
ET
BT
/T1_1 1 Tf
10 0 0 10 351.81924 524.99997 Tm
( )Tj
0 0 1 rg
/T1_0 1 Tf
-16.78192 0 Td
(http://ard.bmj.com/content/73/2/349)Tj
0 g
/T1_1 1 Tf
T*
(Updated information and services can be found at: )Tj
ET
84 511 m
511 511 l
0 0 m
S
BT
ET
BT
/T1_2 1 Tf
10 0 0 10 184 483 Tm
(These include:)Tj
ET
BT
/T1_0 1 Tf
12 0 0 12 125.31604 450.99997 Tm
(Material)Tj
-3.16699 1 Td
(Supplementary)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 217.90002 444.99994 Tm
( )Tj
0 0 1 rg
/T1_0 1 Tf
-3.39 0 Td
(46.DC1)Tj
T*
(http://ard.bmj.com/content/suppl/2013/01/28/annrheumdis-2012-2026)Tj
0 g
/T1_1 1 Tf
0 1.00001 TD
(Supplementary material can be found at: )Tj
ET
BT
/T1_0 1 Tf
12 0 0 12 99.30817 425 Tm
(References)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 379.05939 416.99997 Tm
( )Tj
0 0 1 rg
-2.72401 0 Td
(#BIBL)Tj
/T1_0 1 Tf
-16.78193 0 Td
(http://ard.bmj.com/content/73/2/349)Tj
0 g
/T1_1 1 Tf
0 1 TD
(This article cites 36 articles, 12 of which you can access for free at: \
)Tj
ET
BT
/T1_0 1 Tf
12 0 0 12 119.29999 384.99997 Tm
(service)Tj
-2.83299 1 Td
(Email alerting)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 184 388.99997 Tm
(box at the top right corner of the online article. )Tj
T*
(Receive free email alerts when new articles cite this article. Sign up i\
n the)Tj
ET
84 362 m
511 362 l
0 0 m
S
BT
ET
BT
/T1_0 1 Tf
12 0 0 12 95.98444 323.99997 Tm
(Collections)Tj
3.00099 1 Td
(Topic)Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 184 338 Tm
(Articles on similar topics can be found in the following collections )Tj
ET
BT
/T1_1 1 Tf
10 0 0 10 310.16 288.99991 Tm
( \(4253\))Tj
0 0 1 rg
-11.616 0 Td
(Connective tissue disease)Tj
0 g
13.55896 1 Td
( \(5144\))Tj
0 0 1 rg
-13.55896 0 Td
(Immunology \(including allergy\))Tj
0 g
12.28098 1.00001 Td
( \(4951\))Tj
0 0 1 rg
-12.28098 0 Td
(Musculoskeletal syndromes)Tj
0 g
11.78299 1 Td
( \(4641\))Tj
0 0 1 rg
-11.78299 0 Td
(Degenerative joint disease)Tj
ET
84 275 m
511 275 l
0 0 m
S
BT
ET
BT
0 g
/T1_0 1 Tf
12 0 0 12 84 254 Tm
(Notes)Tj
ET
84 182 m
511 182 l
0 0 m
S
BT
ET
BT
0 0 1 rg
/T1_0 1 Tf
10 0 0 10 84 143.99997 Tm
(http://group.bmj.com/group/rights-licensing/permissions)Tj
0 g
/T1_1 1 Tf
T*
(To request permissions go to:)Tj
ET
BT
0 0 1 rg
/T1_0 1 Tf
10 0 0 10 84 109.99997 Tm
(http://journals.bmj.com/cgi/reprintform)Tj
0 g
/T1_1 1 Tf
T*
(To order reprints go to:)Tj
ET
BT
0 0 1 rg
/T1_0 1 Tf
10 0 0 10 84 75.99997 Tm
(http://group.bmj.com/subscribe/)Tj
0 g
/T1_1 1 Tf
T*
(To subscribe to BMJ go to:)Tj
ET
BT
0 0 1 rg
/T1_1 1 Tf
8 0 0 8 392.87988 780 Tm
(group.bmj.com)Tj
0 g
-14.06299 0 Td
( on May 3, 2017 - Published by )Tj
0 0 1 rg
-8.28097 0 Td
(http://ard.bmj.com/)Tj
0 g
-8.11399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
168 0 obj
<>/Filter/FlateDecode/Height 155/Length 8612/Name/X/Subtype/Image/Type/XObject/Width 246>>stream
H pƿk$!@` ghôUZ툢APutZ:mv@P
6ElBHH ٜ{dw~IQBog&;v>G)""Nk-B8E'ҷD!H"[p"}No-B8E'ҷD!H"[p"}No-B8E'ҷD!H"[p"}No-B8E'ҷD!H"[p"}No%ᒌN)5\-ya|i;Y(+]|JAnjİ(&O&˼$&2j'3QX(A3K㕎e*I槬l"/o,FkwmEӲf>QmyIxǂ =b[;vwK>G/q,md(2//3~W=>)×ţAq`Pr=N?:~Kkۺ+G_?oz;|^|Tl`4[z\k7} L[eO{O[7{]ȟ_W;x,=p
aS8Nk:;ܭAe4qZw}<1T]^w(8wLfkۗŎaT`ݞC{>ss|o|厘a5tZ[o@^>#j`N8d/8az7*VF"V9fogm^KkoX-Bϱ˽_d| $ի->!H,L1olzhD |HHV#㑶Cn\X6=C(&|?nV/M1%Lx;(RԷ˶ 6a.1ᅵzPH9RqR+C3/^^X\08]eab/imxN)NbNss/TL)ehbS&*&|Ƒp=uBҶp;"L(5w5Z$%Xt??^lV41oUvw[5* N8@m[>jF
ZS Qxѿ|| ;*jڸS!-ZwˬpUZM\ h
xټ`<ԷïsXxN)W]6ASqpJqOnth
q!KMNRVȋ*G/Qls6Kc+Ũ|l_?* J"|xbUJ8y들MI08R-S/{]JoB8Ɇ 5mgl_RH#>]{+^GG>wX?
Eg$q٩)9,3!z_?!w;-/*?TC=F`S*Aw2ײ s=q]+JҬlإ@>9tŽW,gx
p5ׂMx^dQq,IPnTԶz
.Gyi_fIXN23p]Ӝ4c^`eڤ1~rxN]e'̌
ax@(B[xkV`]~յtM_*/x~W(9GW=t6 U;P0UT^qZǦKrsvaa`]|\8jLxZVxO^2x$+*nԌ!
VщߛT
9p|T\jQ$|X %?$[rjuMgR#DTuynbOv7hތ#2yQM#/pGQc)/ٍ~t_#o<5psGp㸖cw f[mwG҂;)}wJzvK+:P#w pzVH7^=Z3% -eYFgZ rjbfw߮DpI%WޤLsbT\y_xR5;.(>qw&kF8wz|VW9g_s8K82kṙf>'P
?n:r71 @SSR*J{x@fNٹ.Im֭;LWjhˮ&3&:kyJf#sɱbg=
ǟpVLCDyTW]^b
XƁ;X6jC8@} e%uq+M7)/l2+>itP"ɸv,a
P /pG1S
gUc_D{]Z;(re5 <Щ%2LċR-[70sLŢ)3*_} 7q^q\J_l'e2C9@I[@(`&ܴ0IaJq !3O r!daL4G
Em_uKk0N
oed{>VDTPE$7s56p+z8#я`z%RL! `/(gaL|]}Ska;Ě,Y@MXR}?)|K8ҵ;~k @ѯr{ΙBr5-?rVkG*<&=:Z)2-boi?S?!x 2-Fjpqqpݾy{qM__T!8RLVǤhExlO{ƍ*?/kєY/Gd&luy)R5|H8ic0HB"}~ sspP*(Fƣ[lL.ls;έfu1zL'@.- KQRBVQMKj'̄=+=l'5_iaDN3?-~r?f ?Nm3XA%{6@JU6JKv_Ik!v!5~XM}NǛ*U!&duͨ9mE"\ƕZOsp=6͋L5dAhz|5J8ٰ-b@
uڟO!Cv.#)8C뚘GIΟrZv1
~)_\Te ^B2{3A}su$#a]M(űO՞g
|b4qR>S]V63D!:$H*ZּlW&[oVk4'<>|%ŃԨ` ؞3 grGL!G1f?LQ T
xE/H&Fك6Ӳ-O%(RjT@g>qǁqVh'UBן$/lp>Α!5*NpTWM)1H%rΤ.ЕťM;>yȥ&E;}C?)ΖT.izzr1Fe$(nl;]#۫_fZR<{,0@jH,u5
URHL+(e&8,~F; 00bE.rx~B(xF$.Z
M?[7P2pFcۚnV@x*4PLH8wf8LUG).c:;G}F_xG`{lPp%W͟P&!rp`9J9UpbuM{i0.kR`>LW|Mo\l`@&
H{̷m22#0qDӄY+}˂zpȒ0)N5xrj{WO7M1%k5%k1n{MppL%T廝`ÃqppsK Tvw焃_L}~$FV~ng|3^!<+ǾT>v8B꘦MUZm$;٥f}R0fbpp